After helping families finance critical treatments through Ketto, Kunal Kapoor is now focused on preventing those medical emergencies befor...

Glenmark Pharmaceuticals has launched a generic version of Olanzapine injection in the United States, offering a treatment for schizophreni...

Five young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials containe...

Chinese tech giant Kuaishou's AI video unit, Kling AI, has secured over 19 billion yuan ($2.80 billion) in funding from investors including...

He added a report by the Japanese newspaper The Yomiuri Shimbun, which noted that these initiatives, valued at approximately 2 trillion yen...

Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...

Adani Group and Abu Dhabi's International Holding Company are set to invest a massive $11.5 billion in a new Odisha aluminium plant. This a...

Nestle is set to eliminate all artificial food colorings globally by the end of 2026, a significant move by the major food producer. This i...

Despite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...

China's central bank significantly boosted liquidity, injecting 600 billion yuan via overnight reverse repos, doubling Monday's debut. This...

China's central bank has introduced overnight reverse repo operations for the first time, injecting 300 billion yuan to manage liquidity. T...

ITC's business with major shareholder British American Tobacco (BAT) saw a 10% expansion in sales to Rs 1,587 crore in FY26, though dividen...

British American Tobacco's Indian entities received ₹3,895.74 crore in dividends from ITC in FY26, a slight decrease from the previous year...

Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...